A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches
- 2.3k Downloads
Multiple sclerosis (MS) is a common complex neurodegenerative disease of the central nervous system. It develops with autoimmune inflammation and demyelination. Genome-wide association studies (GWASs) serve as a powerful tool for investigating the genetic architecture of MS and are generally used to identify the genetic factors of disease susceptibility, clinical phenotypes, and treatment response. This review considers the main achievements and challenges of using GWAS to identify the genes involved in MS. It also describes hypothesis-driven studies with extensive genome coverage of the selected regions, complementary to GWASs. To date, over 100 MS risk loci have been identified by the combination of both approaches; 40 of them were found in at least two GWASs and meet genome-wide significance threshold (p ≤ 5 × 10−8) in at least one GWAS, whereas the threshold for the rest of GWASs was set in our review at p < 1 × 10−5. Yet, MS risk loci identified to date explain only a part of the total heritability, and the reasons of “missing heritability” are discussed. The functions of MS-associated genes are described briefly; the majority of them encode immune-response proteins involved in the main stages of MS pathogenesis.
KeywordsMultiple Sclerosis Multiple Sclerosis Patient Genetic Risk Score GWAS Data Genotype Imputation
This work was supported by the Russian Foundation for Basic Research (projects 13-04-40281-H, 13-04-40279-H, and 15-04-04866-A).
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- Burdett T, Hall PN, Hasting E, Hindorff LA, Junkins HA, Klemm AK, MacArthur J, Manolio TA, Morales J, Parkinson H, Welter D (2015) The NHGRI-EBI Catalog of published genome-wide association studies. http://www.ebi.ac.uk/gwas. Accessed 17 April 2015
- Favorov AV, Andreewski TV, Sudomoina MA, Favorova OO, Parmigiani G, Ochs MF (2005) A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics 171:2113–2121. doi: 10.1534/genetics.105.048090
- Gourraud PA, International Multiple Sclerosis Genetics Consortium (IMSGC) (2011) When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis. Genet Epidemiol 35:568–571. doi: 10.1002/gepi.20592 PubMedPubMedCentralGoogle Scholar
- Guerini FR, Ferrante P, Losciale L, Caputo D, Lombardi ML, Pirozzi G, Luongo V, Sudomoina MA, Andreewski TV, Alekseenkov AD, Boiko AN, Gusev EI, Favorova OO (2003) Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology 61:520–526CrossRefPubMedGoogle Scholar
- http://www.genecards.org. Accessed 20 April 2015
- http://www.ncbi.nlm.nih.gov/gene. Accessed 20 April 2015
- http://amigo.geneontology.org/amigo/landing. Accessed 25 April 2015
- http://revigo.irb.hr/. Accessed 25 April 2015
- International Multiple Sclerosis Genetics Consortium (IMSGC), Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance MA, Haines JL (2010) Evidence for polygenic susceptibility to multiple sclerosis—the shape of things to come. Am J Hum Genet 86:621–625. doi: 10.1016/j.ajhg.2010.02.027 CrossRefGoogle Scholar
- Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier SJ, Moré JM, Gourraud PA, McCauley JL, Beecham AH, International Multiple Sclerosis Genetics Consortium, Piccio L, Herbert J, Khan O, Cohen J, Stone L, Santaniello A, Cree BA, Onengut-Gumuscu S, Rich SS, Hauser SL, Sawcer S, Oksenberg JR (2015) An ImmunoChip study of multiple sclerosis risk in African Americans. Brain 138:1518–1530CrossRefPubMedPubMedCentralGoogle Scholar
- Matesanz F, González-Pérez A, Lucas M, et al. (2012) Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One 7:e36140. doi: 10.1371/journal.pone.0036140
- Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y, Caverzasi E, Lindberg RL, Kappos L, Hauser SL, Oksenberg JR, Henry R, Pelletier D, Baranzini SE (2015) Genetic associations with brain cortical thickness in multiple sclerosis. Genes Brain Behav 14:217–227CrossRefPubMedPubMedCentralGoogle Scholar
- Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFN[beta]-1b and a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium, Esposito F, Reischl J et al (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 70:897–912. doi: 10.1002/ana.22609 CrossRefPubMedPubMedCentralGoogle Scholar
- Rasmussen HB, Kelly MA, Clausen J (2001) Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3′ untranslated region of the major histocompatibility complex class II transactivator gene. Hum Immunol 62:371–377. doi: 10.1016/S0198-8859(01)00215-4 CrossRefPubMedGoogle Scholar
- Wang L, Mousavi P, Baranzini SE (2015) iPINBPA: an integrative network-based functional module discovery tool for genome-wide association studies. Pac Symp Biocomput 2015:255–266Google Scholar